Medicus Sciences Acquisition Corp. Warrant
MSACW
MSACW was delisted on the 17th of February, 2023.
0 hedge funds and large institutions have $0 invested in Medicus Sciences Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 14 closing their positions.
100% less funds holding
Funds holding: 16 → 0 (-16)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $305K → $0 (-$305K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DMKJ
David M. Knott Jr
|
-$256K |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.9K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$5.65K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$5.2K |
| 5 |
CAC
Cowen and Company
New York
|
-$4.76K |
MSACW Hedge Fund Activity: Q1 2023 in Review
0 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Warrant (MSACW) for Q1 2023, worth a combined $0 — down 100% from $305K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of MSACW and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was David M. Knott Jr, exiting entirely with an estimated $256K sold.
- 0 institutional investors held Medicus Sciences Acquisition Corp. Warrant (MSACW) as of Q1 2023, down from 16 in Q4 2022.
- Funds reported $0 of Medicus Sciences Acquisition Corp. Warrant stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Medicus Sciences Acquisition Corp. Warrant positions in Q1 2023 and 14 closed out, a net change of -14 holders.
- The largest Medicus Sciences Acquisition Corp. Warrant seller in Q1 2023 was David M. Knott Jr, an estimated $256K sold.
Based on aggregated 13F filings for Q1 2023.